AI assistant
Aqua Bio Technology — Share Issue/Capital Change 2024
Jan 30, 2024
3535_rns_2024-01-30_4584ad4d-9724-480f-987f-b22f43e4c246.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
AQUA BIO TECHNOLOGY ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING
30.1.2024 10:34:31 CET | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
Reference is made to the announcement by Aqua Bio Technology ASA on 30 January 2024 concerning, among other things, a private placement with total gross proceeds of approximately NOK 12.46 million and a contemplated subsequent offering (the "Subsequent Offering").
| Date on which the terms of the Subsequent Offering was announced: | 29 January 2024 |
|---|---|
| Last day including right: | 30 January 2024 |
| First day excluding right: | 31 January 2024 |
| Record date: | 1 February 2024 |
| Resolution date: | 30 January 2024 |
| Maximum number of new shares: | 1,000,000 |
| Subscription price: | NOK 5 |
| Shall the rights be listed | No |
The formal resolution related to the Subsequent Offering will be made by the board of directors at a later time, and further information will be given in due course.
This information is published in accordance with the requirements of the Continuing Obligations.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Håvard Lindstrøm, 004794132288, [email protected]
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.